All
Design of Poly(lactic-co-glycolic Acid) (PLGA) Nanoparticles for Vaginal Co-Delivery of Griffithsin and Dapivirine and Their Synergistic Effect for HIV Prophylaxis
Yang H, Li J, Patel SK, Palmer KE, Devlin B, Rohan LC. Pharmaceutics 11, no. 4(16 April 2019): 184 More »
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES
McBride JW, Malcolm RK, Dias N, Cameron D, Offord RE, Hartley O, Kett VL, Devlin B, Boyd P. International Journal of Pharmaceutics. 15 Apr 2019: epub ahead of print. doi.org/10.1016/j.ijpharm.2019.04... More »
Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring
Noguchi LM, Hoesley C, Kelly C, Scheckter R, Bunge K, Nel A, Marzinke MA, Hendrix CW, Dezzutti CS, Hillier SL, Bogen DL, Piper JM, Beigi RH. Antimicrobial Agents and Chemotherapy. 63, vol. 3 (2019... More »
After The Ring Study: DREAM
Learn about IPM's DREAM open-label extension (OLE) study, a "follow-on" study that provided the active ring to former Ring Study participants for one year. More »
2018 Annual Report: On Her Own Terms
Women are at the center of IPM's work and our 2018 annual report, which summarizes recent progress with HIV prevention and other sexual and reproductive health technologies IPM designed to give women... More »